Endothelin-1 is a key candidate to exert pathophysiological effects on cardiomyocytes derived from hypertrophic cardiomyopathy-induced pluripotent stem cell  by Tanaka, Atsushi et al.
Session 10: Cardiology, Hypertension, Vascular Disease
Endothelin in myocardial infarction
Theoﬁlos M. Kolettis
University of Ioannina, Greece
E-mail address: thkolet@uoi.gr
The effects of ET-1 on myocardial necrosis: Myocardial infarction
increases plasma ET-1 levels shortly after acute coronary occlusion,
causing release from intracellular-storages and de novo production. The
effects of ET-1 on the ischaemic and necrotic areas in the absence of
reperfusion are debated, but ET-1mayplay a role in reperfusion injury. In
in vivo rat-models of ischaemia-reperfusion, ETA- or dual-(ETA and ETB)
receptor blockade have been shown to decreasemyocardial necrosis and
improve left ventricular haemodynamics. Importantly, favourable results
were demonstrated in a recent small-scale clinical study, in which short-
term, selective ETA-receptor blockade prior to percutaneous coronary
intervention improved myocardial perfusion, decreased infarct size and
improved left ventricular function. ET-1 and sympathetic stimulation:
During acute myocardial infarction, ET-1 increases catecholamine-
release from the adrenal glands and modulates norepinephrine-release
in sympathetic nerve-endings in the ventricular myocardium. These
effects result in local norepinephrine-release via ETA-receptor activation,
whereas the ETB-receptor appears to exert a protective role by
decreasing early sympathetic drive. Arrhythmogenesis: ET-1 exerts
signiﬁcant electrophysiologic effects and contributes to ventricular
arrhythmogenesis. ET-1 induces spontaneous calcium-transients, lead-
ing into early afterdepolarizations, and inhibits the delayed-rectiﬁer
potassium-current. In the in vivo rat-model of myocardial infarction
without reperfusion, lower incidence of ventricular tachyarrhythmias
and shorter episode duration were reported after selective ETA-receptor
blockade, resulting in lower arrhythmic-mortality. In the same animal
model, dual (ETA and ETB) receptor blockade decreased arrhythmo-
genesis, but this effect was evident only during the later-phase of acute
infarction. These results point towards an arrhythmogenic effect of ET-1
during acute infarction, mediatedmainly by the ETA receptor, consisting
of increased sympathetic activation and enhanced repolarization in-
homogeneity. The restoration of blood-ﬂow after a prolonged ischaemic
period causes marked electrophysiological changes and causes a second
wave of myocardial necrosis, associated with arrhythmogenesis. Given
the possible role of ET-1 in reperfusion injury, the antiarrhythmic
potential of ET-receptor blockade during ischaemia-reperfusion has
been subject of research for over a decade. However, hitherto studies
have produced conﬂicting results, possibly due to differences in
experimental-protocols, including ex vivo and in vivo models, and the
time-window for arrhythmia-recording. Moreover, exogenously admin-
istered ET-1 during ischaemia-reperfusion in some studies may even
exert antiarrhythmic effects, possibly via a preconditioning effect.
Conclusions: The effects of ET-1 during myocardial ischaemia and
infarction constitute an intriguing topic with potential clinical ramiﬁca-
tions. Further research is required on the arrhythmogenic effects of ET-1
during acute myocardial infarction, placing emphasis on those observed
during the pre-hospital phase. Since ventricular tachycardia and
ventricular ﬁbrillation shortly after acute coronary occlusion account
for the vast majority of sudden cardiac death cases, prompt understand-
ing of the underlying pathophysiology may lead to effective preventive
therapeutic strategies.
doi:10.1016/j.lfs.2013.12.187
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Background. Despite the accumulating genetic and molecular
understandings into hypertrophic cardiomyopathy (HCM), it remains
unclear how this condition develops and worsens pathologically and
clinically in terms of the genetic-environmental interactions. Thus,
establishing human disease models for HCM would help us to evaluate
the disease mechanisms and novel therapeutic strategies. Emerging
patient-speciﬁc induced pluripotent stem cell (iPSC) techniques hold
much promise for these tasks. Hypothesis. Interactions between genetic
backgrounds and environmental factors are involved in the progression
of HCM.Methods. To clarify candidate disease-promoting environmental
factors, iPSCs fromunrelated three patientswithHCMand three healthy-
control subjectswere generated. The cardiomyocytes differentiated from
each iPSC line were stimulated by several cardiomyocyte hypertrophy-
promoting factors. The HCM pathological phenotypes were examined
based on themorphological properties, such as cell size and intracellular
myoﬁlament structures, in randomly chosen cardiac troponin-T-positive
singled cardiomyocytes. Next, a high-speed video imaging with motion
vector prediction algorithm revealed physiological contractile dynamics
in the iPSC-derived singled cardiomyocytes. Results. Control- and HCM-
iPSC-derived cardiomyocytes were similar under the basal condition in
pathological features and contractile dynamics. However, only the HCM-
iPSC-derived cardiomyocytes showed pathological phenotypes, such as
cardiomyocyte hypertrophy and facilitated intracellular myoﬁlament
disorganization in the presence of endothelin-1 (ET-1) administration
with a dose-dependent manner. Moreover, physiological analyses
revealed ET-1-induced contractile dispersion in the self-beating HCM-
iPSC-derived cardiomyocytes. Finally, these deleterious effects were
rescued by blocking the endothelin receptor type-A. Conclusions.
Interactions between genetic backgrounds and the environmental factor,
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ET-1, promoted the pathophysiological phenotypes of HCM in the iPSC-
derived cardiomyocytes.
doi:10.1016/j.lfs.2013.12.188
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Background: Experimental autoimmune myocarditis (EAM) is
a mouse model of inﬂammatory cardiomyopathy. The amount of
endothelin (ET) increases according to the disease progression;
however, the pathological role of ET in myocarditis has not been
elucidated. Methods and results: EAM was induced by immunization
of cardiac myosin peptide with complete Freund's adjuvant on days
0 and 7 in BALB/c mice. ET-A/-B dual receptor antagonist SB209670
was administered by continuous infusion from a subcutaneous pump
for 3 weeks. An increase in heart-to-body weight ratio was observed
in SB209670-treated mice compared with vehicle-treated mice. The
heart pathology in SB209670-treated mice was remarkable for gross
inﬂammatory inﬁltration, in contrast to the smaller inﬂammation in
the hearts of vehicle-treated mice. We found that ET blockade
decreased the number of Foxp3+ regulatory T cells and inhibited the
production of immunoregulatory cytokine IL-10 in the heart. ET
blockade also inhibited the expression of suppressor of cytokine
signaling 3 (SOCS3) that plays a key role in the negative regulation of
both Toll-like receptor (TLR)- and cytokine receptor-mediated
signaling. EAM is a CD4+ T cell-mediated disease. CD4+ T cells
isolated from SB209670-treated EAM mice produced less IL-10 and
more inﬂammatory cytokines IFN-γ and IL-17 than those isolated
from vehicle-treated mice. Conclusions: ET receptor antagonist
exacerbated autoimmune myocarditis in mice. ET may play an
important role in the regulation of inﬂammation in myocarditis.
doi:10.1016/j.lfs.2013.12.189
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In engineered cells, endothelin ETA- and ETB-receptors can
heterodimerize. We tested whether this is possible in native tissue.
Therefore, rat mesenteric resistance arteries were maintained in organ
culture for 24 h to upregulate ETB-mediated contractions in addition to
their normal ETA-mediated constrictions. Thereafter the vessels were
cannulated and maintained at constant distending pressure and 37 °C
under a two photon laser scanning microscope. They were then sub-
sequently exposed to ﬁrst 100 nM linear ET-1 (ETB-agonist) taggedwith
Oregon Green 488 (OG488) and then to 16 nM intact ET-1 (ETA/ETB-
agonist) tagged with the rhodamine dye TAMRA. After incubation with
the labeled ligands, the arterial smooth muscle cells in the tunica media
were efﬁciently stained and became visible under the two photon
microscope. Wrinkling of the autoﬂuorescent internal and external
elastic laminae accompanied agonist-induced constriction. TAMRA-ET-1
bound to all smooth muscle cells with a homogeneous cytoplasmic
distributionwhereas similar staining was observed for labeled linear ET-
1 but only on some group of cells. Fluorescence lifetime measurements
were employed to probe the interaction of the two receptor subtypes.
Fluorescence lifetime of OG488, which acted as a donor, was reduced
in the presence of TAMRA, from 2.8 ps to 2.3 ps, which indicates a
ﬂuorescence resonant energy transfer (FRET ), a phenomenonwhich can
take place only if the receptors are in close proximity (b10 nm). The
methodology that is introduced by these preliminary observations may
be useful to asses ET-receptor heterodimerization in biopsies from
relevant experimental animal models and human patients.
doi:10.1016/j.lfs.2013.12.190
Sympathetic endothelin A receptors contribute to the
development of heart failure
Johannes P. Backsa,f, Lorenz L. Lehmanna, Julia Rostoskya,
Sebastian J. Bussa, Walter Mierb, Michael D. Schneiderc,
Rosanna Parlatod, Hermann-Josef Groenee, Masashi Yanagisawaf,
Uwe Haberkornb, Hugo A. Katusa
aCardiology, Heidelberg University, Heidelberg, Germany
bDepartment of NuclearMedicine, University Hospital, Heidelberg, Germany
cBritish Heart Foundation Centre of Research Excellence,
Imperial College London, United Kingdom
dInstitute of Applied Physiology, University of Ulm, Ulm, Germany
eDepartment ofMolecular Pathology,GermanCancer ResearchCenter (DKFZ),
Heidelberg, Germany
fHHMI and Dept. of Molecular Genetics, UTSW Medical Center at Dallas,
Dallas, USA
E-mail address: johannes.backs@med.uni-heidelberg.de (J.P. Backs)
In preclinical heart failure (HF) models, endothelin receptor A (ETA)
antagonists (ETAi) attenuated the disease progression. However, clinical
HF trials failed to demonstrate beneﬁcial effects on cardiac function
and prognosis. We hypothesized that established HF drugs such as
adrenergic receptor blockers interfere with the mechanism of action of
ETAi. Here we report, that mice lacking ETA selectively in sympathetic
neurons (SN-KO) showed less adverse structural remodeling and cardiac
dysfunction in response to pathological pressure overload induced by
transverse aortic constriction (TAC). In contrast, mice lacking ETA
selectively in cardiomyocytes (CM-KO) were not protected against HF.
TAC led to a disturbed sympathetic nerve function as measured by
cardiac norepinephrine (NE) tissue levels and [124I]-MIBG PET, which
was prevented in SN-KO. In co-cultures of cardiomyocytes (CMs) and
sympathetic neurons (SNs), endothelin-1 (ET1) led to a massive NE
release and exaggerated CM hypertrophy as compared to CM mono-
cultures. ETA-deﬁcient CMs gained a hypertrophic response through
wild type SNs but ETA-deﬁcient SNs failed to mediate exaggerated CM
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